S02 36C24824Q0001.pdf

COMBINED SYNOPSIS/SOLICITATION RFQ 36C24824Q0001

General Information

Action Code: Combined Synopsis Solicitation

Document Type: RFQ

RFQ Number: 36C24824Q0001

Posted Date: 6/27/2023

Response Date: 7/14/2023 by 4:00PM EST

Classification Code: 6630

Set Aside: Unrestricted

NAICS Code: 325413

Contracting Office Address

NCO 8

ATTN: John H. Shultzaberger

1601 SW Archer RD

Gainesville, FL 32608

Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in

FAR Subpart 12.6 in conjunction with Part 13, as supplemented with additional information included in this notice. This procurement is being conducted under Subpart 13.5 Simplified Procedures for Certain

Commercial items. This announcement constitutes the only solicitation for this action. Quotes are being requested, and a written solicitation will not be issued.

This solicitation is issued as a Request for Quote (RFQ). This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2023-04 Effective

June 2, 2023.

The Network Contracting Office 8-SAO East intends to award a firm fixed priced contract, providing for all supplies, materials, equipment, labor, supervision, management, and transportation, necessary to furnish

Fecal Occult Blood Cost Per Test in accordance with the below Price Schedule.

Prospective offerors shall be a registered in the System for Award Management (SAM) at http://www.sam.gov to be considered for an award of a federal contract, and registration shall be complete and not missing elements such as representations and certifications.

Tiered Evaluations

TIERED EVALUATIONS INCLUDING LARGE BUSINESS CONCERNS: This solicitation is being issued as tiered evaluation with the following tiers: (1) SDVOSB concerns, (2) VOSB concerns, (3) small business concerns with HUBZone small business concerns and 8(a) participants having priority; and (4) large business concerns. If award cannot be made, the solicitation will be cancelled, and the requirement resolicited.

VENDOR QUESTIONS: All questions regarding this RFQ must be in writing and may be sent by e‐ mail to John.Shultzaberger@va.gov.

ANSWERS TO VENDOR QUESTIONS: Answers to vendor questions will be posted on SAM.gov.

You are reminded that representatives from your company SHALL NOT contact any North Florida/South

Georgia Veterans Health System staff to discuss this RFQ during this RFQ process. All questions and concerns regarding this RFQ shall be directed to John H. Shultzaberger, the Contracting Officer.

QUOTE SUBMISSION: Offers are due on/or before Friday, 07/14/2023 by 4:00 PM

Eastern. Quotes shall be sent by e‐mail “only” to the Contracting Officer (John H. Shultzaberger) at John.Shultzaberger@va.gov. The Government intends to award a Firm Fixed Priced (FFP) contract resulting from this RFQ.

mailto:John.Shultzaberger@va.gov

36C24824Q0001

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

COMBINED SYNOPSIS/SOLICITATION RFQ 36C24824Q0001

General Information

Contracting Office Address

Description

Tiered Evaluations

VENDOR QUESTIONS

ANSWERS TO VENDOR QUESTIONS

QUOTE SUBMISSION

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

B.3 DELIVERY SCHEDULE

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES (DEC 2022)

C.2 52.217-7 OPTION FOR INCREASED QUANTITY—SEPARATELY PRICED LINE

ITEM (MAR 1989)

C.3 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000) ... 61

C.4 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV

2018)

C.5 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020) ... 62

C.6 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.7 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT

STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (MAR 2023)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (MAR 2023)

E.2 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS

AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021)

E.3 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)

E.4 52.216-1 TYPE OF CONTRACT (APR 1984)

E.5 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.6 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018)

E.7 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.8 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (NOV 2021)

E.9 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—

COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEC 2022)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT:

John H. Shultzaberger, Contracting Officer John.Shultzaberger@va.gov Department of Veterans Affairs Network Contracting Office 8 (NCO 8)

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or

[] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] Monthly

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment

Requests.

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO DATE

Statement of Work

I. Introduction

North Florida/South Georgia requires a Cost Per Test (Reagent Rental) for FDA-approved, automated occult blood detection system. Vendor must provide equipment, FDA-approved reagents, supplies, and consumables.

The Vendor shall provide all sites in Pathology & Laboratory Medicine Service for Department of

Veterans Affairs (DVA), North Florida / South Georgia Veterans Health System (NF/SG VHS) laboratories performing tests according to the test menu provided. The vendor(s) selected is responsible for equipment and service components specific to each facility.

Facility Locations:

Department of Veterans Affairs Malcom Randall VA Medical Center 1601 SW Archer Rd Gainesville, FL 32608

Department of Veterans Affairs Tallahassee Outpatient Clinic (OPC) 2181 East Orange Ave Tallahassee, FL 32311

The Villages Outpatient Clinic (OPC) 8900 SE 165th Mulberry Lane The Villages, FL 326162

Jacksonville Outpatient Clinic (OPC) 1536 North Jefferson St.

Jacksonville, FL 32209

Lake City VA Medical Center 619 S. Marion Ave Lake City, FL 32025

Support Services: Vendor shall provide telephone assistance 24-hours/day, 7 days/week 365 days per year. Following determination that service is required, technical on – site support must be provided. Emergency repairs must be provided seven days per week within twenty-four (24) hours of the time of notification of the malfunction. The Vendor shall provide maintenance (labor and parts) to keep the equipment in good operating condition and subject to security regulations. The vendor will provide the Vendor access to the equipment to perform maintenance service according to the maintenance and service terms below.

A. Basic Requirements: The system must contain random access technologies that improve workflow.

1. Microbiology Analytical Systems for DVA, NF/SG VHS:

Expected throughput: Ability to manage testing workflow of high-volume laboratory with approximately 12,000 tests/year where at least 90% of the testing is performed during the day shift (6:30am-4pm) Sunday through Saturday.

Instrument integration plan: DVA, NF/SG VHS facilities on similar platforms; utilizing same supplies.

Specimen integrity evaluation on all supplies as needed at no additional cost.

Quality controls are performed upon arrival of new supplies and weekly due to patient specimen testing.

2. Automation System – Pre/ Post Analytic and Line Processing- DVA, NF/SG VHS

Processing — receives specimen and record time, accession specimens, attach barcode labels to specimen. The information system component of this laboratory automation system (LAS) must be able to communicate with Lab information system for ordering information to be sent from Lab information system to the System manager and shall include but not be limited to order code or name, order priority, type of specimen, accession number, container id, collect date and time, and receipt date and time.

Patient Identification- the barcode of the patient specimen must be validated multiple times throughout the automation system to always assure positive patient identification.

Optimized automated delivery of specimens to Microbiology analyzers for parallel processing to provide best turnaround times and meet specimen handling requirements.

Automated tracking of specimen location and testing status of a specimen.

Capping and recapping system in an enclosed environment to prevent distribution of bio-hazardous aerosols.

3. Reagents and Supplies:

Inventory Management: The Vendor is required to provide a continuously stocked inventory of reagents, required consumable supplies including all routinely replaced parts, disposables and any other materials required to properly perform tests on the equipment. Unexpected changes in methodology/technology shall be at the expense of the vendor. Alert/Notification of all technical advisory/recalls/alerts, prior to or simultaneously with field alerts should be forwarded to lab chiefs or designee. Separate deliveries of products shall be shipped to each site (DVA, NF/SG VHS facilities). Failure to reserve adequate inventory will result in default.

Items Included: The vendor shall provide/install any routine and special items required to operate / maintain the equipment/analyzer in optimal condition such as but not limited to linearity standards, consumable equipment parts, required replacement parts for maintenance or service etc. Any items excluded by the vendor but required for operation of the system at any time, must be delineated in their technical proposal. The cost of any excluded items must be disclosed in the cost proposal.

Special Handling for Emergency Orders of Supplies: If additional requests for emergency supply delivery are required by the government, the Vendor shall honor them until the arrival at the government site of the monthly standing order or routine supply delivery. If the consumables are found to be defective and unsuitable for use with the Vendor's equipment, or the Vendor has failed to comply with the requirements for routing supply delivery or inventory management, the

Vendor is required to deliver the consumable supplies within 24 hours of receipt of a verbal order for priority delivery from the government activity. If either circumstance has occurred, the

Vendor shall deliver to the government site, in the most expeditious manner possible, without additional cost to the government, the necessary consumables in sufficient quantity as required to allow operation of the Vendor's equipment for one week (under normal government test load volume).

Quality of Reagents, Supplies and Disposables: The Vendor shall assure that all supplies provided/ordered for use on their equipment will be of the quality necessary to produce a quality product. The reagent quality must be high enough to satisfy proficiency testing standards of the

College of American Pathologists (CAP) and the Joint Commission on Accreditation of Health

Care Organizations (JCAHO). In the event that the supplies are found to be defective and unsuitable for use with the Vendor's equipment or the Vendor has failed to comply with the requirements herein, the Vendor is required to deliver the supplies within 24 hours of receipt of the verbal order, if verbal order is received by 1 pm EST time, for priority delivery from the government activity. This shall be done at no cost to the government, in sufficient quantity as required to allow operation of the Vendor's equipment for one week (under normal government test load volume). The vendor shall reimburse each facility for any costs/supplies related to tests performed by another vendor or sent to a referral laboratory when reagents were not available due to product issues or instrumentation failure.

Returned Goods: The VA is responsible for inspecting all products shipped hereunder and give the Vendor written notice of rejection within thirty (30) calendar days following receipt or installation by the Vendor. After acceptance, no products purchased hereunder may be returned without the prior authorization of the Vendor and in conformity with their return policy. All returns of non-defective products are subject to a restocking charge. No returns will be authorized after

120 days following shipment to VA

Shipping Charges: For reagents with hazardous constituents, vendor must provide a mechanism for the Laboratory to meet local discharge requirements. No delivery charges for shipping or fee handling.

B. Additional System Requirements:

Upgrades or Replacement: Request for instrumentation upgrades or replacement, due to workload increase, excessive instrumentation failures/malfunctions, breakdowns, or service calls will be evaluated as needed/annually with communication to the vendor for modification of the contract. A high incidence of such problems with any equipment/analyzer supplied may indicate probable non-compliance with the terms of this contract and will entitle the facility/clinic to its replacement with another analyzer(s) that can produce the required criteria of this contract satisfactorily to the user. Removal of instrument by the vendor shall be performed within 60 days after request.

Patient Mean Analysis Quality Control program: Required to have a QC program available on instruments or through middleware to monitor trends of test methods.

Comprehensive on-board QC Program, including Troubleshooting or System Validation QC material. The system must have quality control data storage and reporting capabilities, the ability to view and print daily and monthly QC results, troubleshoot unsatisfactory results and system errors, validate archive data document all information as applicable to the Polymedco system.

Upgraded Software/ Equipment: The Vendor shall provide all upgrades to the equipment hardware and operating system software without additional charge to the government. These enhancements to the Vendor's equipment shall be delivered to the government site and installed by the Vendor within 60 days of their issuance or date of first commercial availability.

Bar Codes: All bar code readers must be capable of reading and decoding any label when manually applied to a specimen tube in accordance with the guidelines described in the Clinical and Laboratory Standards Institute (CLSI) standard, Laboratory Automation: Bar Codes for

Specimen Container Identification, CLSI Document Auto2-A, Approved Guideline, Vol. 20, No.

19, October 2005.

New Test Methods: New tests on-line vendor/technical support specialist shall perform all validation studies including installation/set-up, correlation studies (evaluation/comparison data sufficient to satisfy CAP standards) and normal range studies at no initial charge.

C. Maintenance and Service Support Requirements:

Minimal System Maintenance required, including limited reagent preparation prior to use.

Computer Patient Data Handling: No hardware, containing any VA patient information is to be removed from any location, without the approval and removal of data by the VA information technology department. Failure to comply with this VA requirement may result in prosecution.

Preventative Maintenance: Vendor shall provide regular, scheduled maintenance to assure the continued reliable operation of the equipment. These preventive maintenance visits shall be of a frequency that conforms to the manufacturer's operation and maintenance instructions for the supported equipment. Minimum of 2 per year per instrument unless documentation for volume performed denotes not required for optimum quality of operation.

Emergency Repair: Emergency repairs shall be performed after notification that the equipment is inoperative. The Vendor shall provide the government with a designated point of contact and shall make arrangements to enable its maintenance representative to receive such notification.

The Vendor shall perform emergency repair service within 24 hours of time of notification of the malfunction except when an ordering facility elects reduced service at contract agreed reduction. The Vendor shall provide all parts and labor needed to repair the malfunction. Travel, per diem and other expenses associated with the repair shall be borne by the Vendor. The

Vendor shall furnish a malfunction incident report to the installation upon completion of each maintenance call. The report shall include, as a minimum, the following: (a) date and time of arrival. (b) Serial number type and model numbers(s) of equipment (c) time spent for repair, (d) description of malfunction and (e) proof of repair.

Maintenance Credit for Equipment Malfunction: If a machine remains inoperative due to a malfunction through no fault or negligence of the government for a total of 24 hours or more, the

Vendor shall be assessed damages at the rate of 1/30 of the preceding average three month

CPT billings times the total number of days certified as downtime for each incident shall start from the time the user makes a bona fide attempt to contact the Vendor's designated representative at the prearranged contact point until the machine is returned to good operating order less any non-contracted maintenance (emergency repairs) days.

Replacement of Laboratory Equipment: During the contract period, should the repair record of any laboratory equipment reflect a downtime of 10% or more of the normal working days in one calendar month, a determination will be made by the representative of the government to replace the initial laboratory equipment with new equipment. The responsibility of maintaining the equipment furnished in good condition shall be solely that of the Vendor.

Failure Mean Time Disclosure: The Vendor shall state the failure mean time (between failure and mean time to repair) for each piece of equipment offered. The Vendor shall provide emergency backup equipment.

FDA Approved Instruments and Methods: Only instruments which are FDA approved will be considered and must be operational and interface with VA Laboratory Computer systems and upgrades. Test methods must be FDA approved with limited recalls due to product failures. This must be a "turn-key" system.

Operator Procedure Manuals: Two Operator and Service manuals along with CLSI compliant procedures must be furnished for each instrument model supplied.

D. Training and Technical Service Training:

On-site training by vendor shall also be supplied to all laboratory staff as needed.

Vendor shall provide/install/train users on the data management system within house training.

On-site refresher training in renewal option years of the contract shall also be made available annually.

In addition, the Vendor shall provide supplemental operating training to above government personnel, without additional charge to the government, upon installation of the upgrade in equipment hardware or operating system software connected with the operation of an instrument already furnished.

The Vendor, at his/her discretion, may make additional training available at his/her facility on terms and conditions mutually agreed upon by the agency and the Vendor.

E. Installation and Initial Set Up:

SITE PREPARATION: Site preparation specifications shall be furnished in writing by the Vendor as a part of the equipment proposal. These specifications shall be in such detail as to ensure that the equipment to be installed shall operate efficiently and conform to the manufacturer's claimed specifications.

SPACE REQUIREMENTS, SYSTEM SPECIFICATIONS ETC.: Configuration of the proposed equipment must be able to conform to the space previously allotted for this function. System specifications must all be disclosed in the proposed space. Crossover from current to new instrumentation must be performed timely with no interruption in patient care laboratory service.

OWNERSHIP OF EOUIPMENT: Ownership of the equipment shall remain with the Vendor. All accessories (unused consumables, etc.) furnished by the Vendor shall accompany the equipment when returned to the Vendor. The Vendor, upon expiration of order(s), at termination and/or replacement of equipment, shall remove the equipment. The Vendor shall disconnect the analyzer (gas, water, air, etc.) and shall be responsible for decontamination of the system, packing and shipping required to remove the analyzer within ten (10) calendar days.

STANDARD AND ACCEPTANCE OF PERFORMANCE: This paragraph establishes a standard of performance that must be met before any equipment listed on the deliver order is accepted by the government. This also includes replacement, substitute machines and machines that are added or field modified after a system has completed a successful performance period.

Operational use time for performance testing for a system is defined as the accumulated time during which the machine is in actual use. System failure downtime is that period of time when any machine in the system is inoperable due to equipment failure. Downtime for each incident shall start from the time the government makes a bona fide attempt to contact the Vendor's designated representative at the prearranged contact point until the system or machine(s) is returned to the government in proper operating condition.

During the performance period for a system, a minimum of 100 hours of operational use time with productive or simulated work will be required as a basis for computation of the effectiveness level. However, in computing the effectiveness level, the actual number of operational use hours shall be used when in excess of the minimum of 100 hours.

The government will maintain appropriate daily records to satisfy the requirements of this paragraph and shall notify the Vendor in writing of the date of the first day of the successful performance period. Operations use time and downtime shall be measured in hours and whole minutes.

GOVERNMENT's RESPONSIBILITY: The user will perform routine maintenance and cleaning as required in the manufacturer's operation and maintenance instructions. The user will maintain appropriate daily records to satisfy the requirements of this paragraph.

INSTALLATION PROCEDURES:

The Vendor shall be responsible for installation, which consists of in- house delivery, positioning, and mounting of all equipment listed on the delivery order and connections of all equipment and interconnecting wiring and cabling if applicable in coordination with the facility

Biomedical engineer. Upon receipt of notice to proceed with installation, it shall be the Vendor's responsibility to inform the Contracting Officer of any problems which may be anticipated in connection with installation, or which will affect optimum performance once installation is completed. In the event that progress of the installation is interrupted through no fault of the

Vendor, the continuous installation referenced in the preceding paragraphs may be terminated until such time as the cause of delay has been eliminated, and then shall be resumed within 24 hours after the Vendor has been notified that work may again proceed.

Upon completion of installation the equipment shall be turned over to the hospital for use. Final acceptance of the equipment and installation will be based upon an inspection and test to be performed within ten (10) calendar days from date of installation. If equipment passes inspection or if acceptance inspection is not conducted within ten (10) calendar days from installation, the

Government will accept installation with guaranteed date commencing ten calendar days after installation

F. Special Requirements for Awarded Vendor:

Vendor must meet, or improve, each Laboratory's existing turn-around times as a minimum, by any change in instrumentation. Proposal should include provisions for back-up instrumentation so the Laboratory can provide essential testing without compromising turn-around for all tests on menu. Method Performance/Comparison shall be at the expense of the Vendor, shall include linearity material and reagents, and be consistent with current CLSI and related documents, JC Standards and Federal Regulations, for the following.

Correlation studies for each analyte. A minimum of 30 samples, spanning the reportable range, shall be run by the present and the new contracted method. Vendor shall analyze numbers and provide statistical data to accept the new method. Statistics shall consist of at least mean, bias, slope, y-intercept, correlation coefficient, analysis, and meet current standards defined by CLSI.

Linearity analysis shall be performed on new contracted instrument(s) for each analyte to determine reportable range with data reduction in accordance with CLSI guidelines.

Precision study shall be performed utilizing normal and abnormal control material. This should consist of a within run precision study of 10 normal and 10 abnormal controls and a day-to-day precision study of normal and abnormal controls.

Reference Range: Determine a reference range for each test following CLSI guideline C-23A.

Samples used for the reference range study must be representative of the patient population being tested. Reference range assessment must be performed for each lab. One of the following protocols should be used:

A verification of the manufacturer's suggested reference range may be performed as long as the suggested range is based on a comparable population of test subjects. The manufacturer must provide specific information defining how the suggested range was determined. A minimum of

30 reference individuals must be used to verify the manufacturer's range. Any apparent outliers should be discarded, and new specimens obtained to provide a statistically valid verification.

If the suggested manufacturer's range is not appropriate for the patient population, a reference range must be established. Establishing a reference must follow CLSI C-28A guidelines. This requires a minimum of 100 reference individuals be used to establish a reference range.

If a laboratory is currently using the proposed instrument/reagent system, the "in-use" reference range can be transferred to the "new" system if a method comparison study between the two systems proves to be acceptable. If comparison studies are not acceptable, then an alternate test must be provided.

All technical procedures must be provided electronically by vendor in CLSI format, using software compatible with each Laboratory's computer system, for local modification to meet

CAP requirements.

Carryover studies must be performed, as applicable, as part of the initial evaluation of the instrument. Vendor shall provide interpretation of raw data for each instrument installed and validate no carryover exists within the test platforms.

Vendor to provide all reagents, calibrators, and controls needed along with technical assistance to perform correlation studies from a single lot at no additional cost for new test methods or changes in test menus. (i.e., vendor is to provide all manpower and reagents/supplies to do correlation studies).

G. Equipment Removal:

The vendor shall remove all equipment within 60 days after notification of the expiration of the terms of this contract but not until the completion of new vendor’s equipment installation inclusive of completed cross over studies.Vendor shall not remove hard drive from premises. All drives with VA information remain the propriety of VA. All service personnel shall be instructed regarding this requirement.

JCAHO, VHA (VETERANS HEALTH ADMINISTRATION) AND OTHER STANDARDS:

a. The Vendor shall notify the VA Contracting Officer immediately of any change in the licensure, or status as non-excluded or sanctioned by HHS (Health & Human Services) or Office of Inspector General.

b. The Vendor shall immediately notify the Contracting Officer of any merger, acquisition, or affiliation agreement; any legal or governmental action initiated against the Vendor for professional negligence, violation of law, bankruptcy, lapse, or material change in liability insurance coverage, any other problem or situation that might impair the ability of Vendor to carry out its obligations under the contract.

c. The Vendor represents and warrants that it is in compliance with Medicare, Medicaid, and any other related Federal or State Statutes, regulations, rules, or policies and that neither they nor their agents, officers, employees, independent practitioners assignees or successors in interest are excluded from participation in the Medicare, Medicaid or related federal or state programs. Further, Vendor shall immediately notify the Contracting Officer of the exclusion from such programs of any of its agents, officers, employees, independent practitioners assignees or successors in interest.

d. HIPAA: Vendor agrees to comply with the requirements of the Health Insurance Portability and Accountability Act (HIPAA) and with the provision of other appropriate federal laws, rule and regulations.

e. Qualifications: Proposals shall be considered only from offerors whose Pathology and

Laboratory Medicine Services are licensed as required by CLIA 88.

f. License: Prior to award the offeror shall submit proof that he holds an un-revoked U.S.

License which is issued required by CLIA 88.

g. Certification: The offeror certifies that he shall comply with the requirements outlined with respect to donors, containers, delivery, etc.

B.2 PRICE/COST SCHEDULE

ITEM INFORMATION

ITEM

NUMBE

R

DESCRIPTION OF

SUPPLIES/SERVI

CES

QUANTI

TY

UNI

T UNIT PRICE AMOUNT

1.00 EA _______________

Instrumentation Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6630 - Chemical Analysis Instruments

500.00 BX _______________

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

10.00 BX _______________

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4.00 RO _______________

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

4,000.00 EA _______________

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

150.00 BX _______________

OCPU-VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

5.00 BX _______________

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2.00 RO _______________

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2,088.00 EA _______________

CPT ESTIMATED ANNUAL TOTAL - 2,088

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

250.00 BX _______________

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

2,500.00 EA _______________

CPT ESTIMATED ANNUAL TOTAL - 2500

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

350.00 BX _______________

OPCU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic

Substance Manufacturing

100.00 BX _______________

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

1,000.00 EA _______________

CPT ESTIMATED ANNUAL TOTAL - 1000

Contract Period: Base POP Begin: 10-01-2023 POP End: 09-30-2024 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 1 POP Begin: 10-01-2024

POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU-VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 2,088

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 2500

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OPCU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025

Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 1000

Contract Period: Option 1 POP Begin: 10-01-2024 POP End: 09-30-2025 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 2 POP Begin: 10-01-2025

POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU-VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 2,088

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 2500

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OPCU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic

Instrumentation Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 1000

Contract Period: Option 2 POP Begin: 10-01-2025 POP End: 09-30-2026 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027

Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 3 POP Begin: 10-01-2026

POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU-VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 2,088

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 2500

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OPCU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 1000

Contract Period: Option 3 POP Begin: 10-01-2026 POP End: 09-30-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028

Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU-VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCS1 4 X 50 INDIVIDUAL SAMPLE BOTTLES

Contract Period: Option 4 POP Begin: 10-01-2027

POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 2,088

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 2500

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OPCU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 4000

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

Instrumentation Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OCPU/VA1 PERSONAL (MAIL IN) PACKS 20 PER BOX

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

TP-5 THERMAL PAPER (PRINTER PAPER)

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

CPT ESTIMATED ANNUAL TOTAL - 1000

Contract Period: Option 4 POP Begin: 10-01-2027 POP End: 09-30-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic

GRAND TOTAL _______________

B.3 DELIVERY SCHEDULE

ITEM NUMBER QUANTITY

DELIVERY

DATE

0001 SHIP TO: Department of Veterans Affairs Malcom Randall VA Medical Center 1601 SW Archer RD

USA

1.00

0002 SHIP TO: Department of Veterans Affairs Malcom Randall VA Medical Center 1601 SW Archer RD

500.00

0003 SHIP TO: Department of Veterans Affairs

Center 1601 SW Archer RD

10.00

0004 SHIP TO: Department of Veterans Affairs

Center 1601 SW Archer RD

4.00

0005 SHIP TO: Department of Veterans Affairs

Center 1601 SW Archer RD

4,000.00

0006 SHIP TO: Department of Veterans Affairs North Florida/South Georgia VHS Lake City VA Medical Center 619 S. Marion Ave, FL 32025

0007 SHIP TO: Department of Veterans Affairs

150.00

Lake City VA Medical Center

0008…